Navigation Links
Oncolytics Biotech Inc. Announces 2007 Third Quarter Results
Date:10/30/2007

of

$38,909, $82,573, $21,396, $109,670, $34,671, $222,376, $36,833, and

$38,152, respectively.

(4) We issued 4,600,000 common shares for net cash proceeds of

$12,063,394 during 2007 (2006 - 284,000 common shares for cash

proceeds of $241,400; 2005 - 4,321,252 common shares for cash

proceeds of $18,789,596).

(5) The long-term debt recorded represents repayable loans from the

Alberta Heritage Foundation. On January 1, 2007, in conjunction with

the adoption of the CICA Handbook section 3855 "Financial

Instruments", this loan was recorded at fair value (see note 1 of the

September 30, 2007 interim financial statements).

(6) We have not declared or paid any dividends since incorporation.

LIQUIDITY AND CAPITAL RESOURCES

As at September 30, 2007, we had cash and cash equivalents (including short-term investments) and working capital positions of $28,191,464 and $26,343,848, respectively compared to $27,613,748 and $25,719,870, respectively for December 31, 2006. The increase in 2007 reflects the cash inflow from financing activities of $12,063,394 offset by cash usage from operating activities and additions to our intellectual property of $10,849,863 and $586,124, respectively.

We desire to maintain adequate cash and short-term investment reserves to support our planned activities which include our clinical trial program, product manufacturing, administrative costs, and our intellectual property expansion and protection. For the remainder of 2007, we are expecting to continue to enroll patients in our existing trials and we also expect to expand our clinical trial program. As well, we expect to continue with our collaborative studies pursuing support for our future clinical trial program. We will therefore need to ensure that we have enough REOLYSIN(R) to supply our clinical trial and collaborative programs. We continue to expect our cash usage i
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related biology technology :

1. The state of global biotech: An Ernst & Young perspective
2. Olympics of biotechnology has international flavor
3. Biotech officials praise focus of new venture fund
4. Getting noticed in Genetown: Wisconsin biotech on display
5. Madison biotech NimbleGen files for IPO; one of states best-funded firms
6. Wisconsin biotech firm receives $107K NIH grant
7. Biotech executive books a career flight thats closer to home
8. Manufacturing partnership will move into biotech and biomedical spaces
9. Wisconsin wont get Georgia biotech without a fight
10. The 10 biggest events shaping biotech in 2006
11. Gala Biotech among companies sold for $3.3 billion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... Researchers have discovered a new explanation for differences in the ... of a certain gene, the more serious the handicap. The ... suspected that it is the amount of copies of the ... in the American Journal of Human Genetics , and ... Froyen connected to VIB, a life sciences research institute in ...
(Date:12/11/2009)... 11 Gwathmey, Inc., a pre-clinical contract ... staph aureus, and cardiovascular disease announces a new ... that Rosalie Dunn, Ph.D., has joined Gwathmey as ... 28 years of experience working with small businesses ... Gwathmey, Dr. Dunn managed multimillion dollar portfolios for ...
(Date:12/10/2009)... Endologix, Inc. (Nasdaq: ELGX ), developer of ... that Dan Lemaitre, former President and CEO of ... effective December 11, 2009. Endologix now has ... Franklin D. Brown, Chairman of the Board, said, ... the Endologix Board of Directors. He has ...
(Date:12/10/2009)... provider of advanced flow measurement, control, and level ... company as Global Level Product Manager effective November ... to enhance market penetration of the level measurement ... Instrument from Lafarge Corp, a manufacturer of building ... and Sales. Bayda will report to Brooks Instrument ...
Breaking Biology Technology:Amount of gene surplus determines severity of mental retardation in males 2Rosalie Dunn, Ph.D., Joins Gwathmey, Inc. as Chief Executive Officer 2Endologix Appoints Dan Lemaitre to its Board of Directors 2Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 2Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 3
... Jan. 3 /Xinhua-PRNewswire-FirstCall/ -- China Technology,Development Group Corporation ... clean and renewable energy products and solutions focusing ... it held a ribbon,cutting ceremony to showcase the ... Zone on December 28, 2007., Accompanied by ...
... Corp.,(Nasdaq Capital Market: ESMC) today announced that its ... Food and Drug,Administration (FDA) to market the MASTER-VU(TM) ... a B-scan probe that,can be interfaced to a ... Sonomed,s proprietary software, thereby converting the,personal computer into ...
... Intercept Pharmaceuticals, Inc., a,clinical-stage biopharmaceutical company developing ... metabolic diseases, today announced the,appointment of Luciano ... of,Chief Scientific Officer. Dr. Adorini brings over ... development, recently serving as Chief Scientific,Officer at ...
Other Biology Technology:CTDC Holds a Ribbon Cutting Ceremony to Showcase First SnO2 Production Line 2CTDC Holds a Ribbon Cutting Ceremony to Showcase First SnO2 Production Line 3Escalon(R) Announces FDA 510(k) Clearance for Sonomed MASTER-VU(TM) B-Scan System 2Escalon(R) Announces FDA 510(k) Clearance for Sonomed MASTER-VU(TM) B-Scan System 3Intercept Pharmaceuticals Names Dr. Luciano Adorini Chief Scientific Officer 2
(Date:12/14/2009)... Convention on Climate Change taking place in Copenhagen, ... Trend, event on Sunday evening to provide a ... of the new ,Environmental Atlas of Europe,. , ... of the European Environment Agency (EEA), the UN ... of short films showing the significance of environmental ...
(Date:12/13/2009)... University researchers has used nanosensors to measure cancer ... Their findings, which appear December 13 in the ... could dramatically simplify the way physicians test for ... , The teamled by Mark Reed, Yale,s Harold ... Tarek Fahmy, an associate professor of biomedical and ...
(Date:12/11/2009)... Malus orientalis species of wild apples that could ... the Middle East and Central Asia. A new study ... varieties from Georgia and Armenia with previously collected ... population and establishes a core collection that will make ... and research communities. , To identify and record the ...
Breaking Biology News(10 mins):'Environmental Atlas of Europe' unveiled at COP15 2Scientists use nanosensors for first time to measure cancer biomarkers in blood 2Understanding apples' ancestors 2New Pap Test Guidelines 3A Start Later Have Fewer 61805 1New Pap Test Guidelines 3A Start Later Have Fewer 61805 2New Pap Test Guidelines 3A Start Later Have Fewer 61805 3New Pap Test Guidelines 3A Start Later Have Fewer 61805 4GetSynchronicity Announces New Website Launch 61802 1Novavax Announces Public Offering of Common Stock 61799 1Novavax Announces Public Offering of Common Stock 61799 2
... New Haven, Conn. In research that could lead to ... Biosciences of Cambridge, Massachusetts, and the University of California, San ... of allergy-induced asthma in mice. They also demonstrated how a ... inhibit asthma symptoms in mice. Their paper is published in ...
... CHAMPAIGN, Ill. By creating a model of the active ... University of Illinois have described a catalyst that acts like ... work in a paper accepted for publication in the ... the journal,s Web site. , Scientists have long been puzzled ...
... team at Northwestern University has demonstrated a tool that ... individual cells. , The tool, called the Nanofountain Probe, ... probe acts like a fountain pen, wherein drug-coated nanodiamonds ... by ,writing, with it. The second mode functions as ...
Other Biology News:Yale team identifies key to potential new treatment for allergy-induced asthma 2New tool for next-generation cancer treatments using nanodiamonds 2New tool for next-generation cancer treatments using nanodiamonds 3
BD BioCoat Laminin 35 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of mouse laminin....
BD BioCoat Collagen I 35 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of rat tail collagen type I....
... is a new product number, created ... If showing no availability yet, please ... (C6671) or contact customer service for ... area 148 cm 2 Mfr ...
... This CLS number is a new ... product number. If showing no availability yet, ... (Z71,371-6) or contact customer service for assistance. ... Comp Dim: surface area 500 cm ...
Biology Products: